Literature DB >> 22483384

Predictors of fluoroscopy time and procedural failure during biventricular device implantation.

Jonathan C Hsu1, Nitish Badhwar, Byron K Lee, Vasanth Vedantham, Zian H Tseng, Gregory M Marcus.   

Abstract

Biventricular device implantation with the insertion of a transvenous left ventricular (LV) lead can be challenging. The aim of this study was to identify predictors of procedural difficulty measured by fluoroscopy time and predictors of LV lead implantation failure. A single-center, retrospective study of 272 consecutive patients who underwent biventricular device implantation from 2004 to 2011 was conducted. Multivariate linear regression was used to assess predictors of fluoroscopy time and logistic regression to identify predictors of LV lead implant failure. The median fluoroscopy time was 36.1 minutes (interquartile range 24.2 to 51.6). After multivariate adjustment, independent predictors of longer fluoroscopy time included a right-sided approach (21.8 minutes longer, 95% confidence interval [CI] 6.8 to 36.9, p = 0.005), previous congenital heart disease surgery (64.6 minutes longer, 95% CI 30.2 to 99.0, p <0.001), and previous failed attempt (30.3 minutes longer, 95% CI 6.0 to 54.5, p = 0.015). Predictors of shorter fluoroscopy time included an LV lead upgrade (7.5 minutes shorter, 95% CI 0.6 to 14.4, p = 0.033), electrophysiology fellow experience (5.4 minutes shorter/year, 95% CI 0.1 to 10.7, p = 0.047), and attending physician experience (1.4 minutes shorter/year, 95% CI 0.01 to 2.9, p = 0.049). Failed implantation occurred in 8% of patients (22 of 272); inability to cannulate the coronary sinus and absent or atretic coronary sinus veins were the most common reasons (8 of 22 failed implants each). A previous failed attempt was the only significant predictor of LV lead implantation failure (odds ratio 33.5, 95% CI 3.2 to 352.6, p = 0.003). In conclusion, 6 patient and operator characteristics predicted LV lead implantation difficulty measured by fluoroscopy time. LV lead implantation failed in 8% of cases, predicted only by a previous failed attempt.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22483384      PMCID: PMC3383869          DOI: 10.1016/j.amjcard.2012.03.015

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Implantation techniques and chronic lead parameters of biventricular pacing dual-chamber defibrillators.

Authors:  Emile G Daoud; Steven J Kalbfleisch; John D Hummel; Raul Weiss; Ralph S Augustini; Steven B Duff; Georgia Polsinelli; John Castor; Tejas Meta
Journal:  J Cardiovasc Electrophysiol       Date:  2002-10

2.  Technical aspects of implantation of LV lead for cardiac resynchronization therapy in chronic heart failure.

Authors:  Josef Kautzner; Lucie Riedlbauchová; Robert Cihák; Jan Bytesník; Vlastimil Vancura
Journal:  Pacing Clin Electrophysiol       Date:  2004-06       Impact factor: 1.976

3.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

4.  Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries.

Authors:  Amy Berrington de González; Sarah Darby
Journal:  Lancet       Date:  2004-01-31       Impact factor: 79.321

Review 5.  Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials.

Authors:  Johannes B van Rees; Mihály K de Bie; Joep Thijssen; C Jan Willem Borleffs; Martin J Schalij; Lieselot van Erven
Journal:  J Am Coll Cardiol       Date:  2011-08-30       Impact factor: 24.094

Review 6.  Role of the preaxillary flora in pacemaker infections: a prospective study.

Authors:  A Da Costa; H Lelièvre; G Kirkorian; M Célard; P Chevalier; F Vandenesch; J Etienne; P Touboul
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

7.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

Authors:  S Cazeau; C Leclercq; T Lavergne; S Walker; C Varma; C Linde; S Garrigue; L Kappenberger; G A Haywood; M Santini; C Bailleul; J C Daubert
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

8.  Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials.

Authors:  David J Bradley; Elizabeth A Bradley; Kenneth L Baughman; Ronald D Berger; Hugh Calkins; Steven N Goodman; David A Kass; Neil R Powe
Journal:  JAMA       Date:  2003-02-12       Impact factor: 56.272

9.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

10.  Implications of laparoscopic cholecystectomy for surgical residency training.

Authors:  D Böckler; J Geoghegan; M Klein; Q Weissmann; M Turan; L Meyer; J Scheele
Journal:  JSLS       Date:  1999 Jan-Mar       Impact factor: 2.172

View more
  2 in total

1.  Implantation of cardiac resynchronization therapy devices using three leads by cephalic vein dissection approach.

Authors:  Alexios Hadjis; Riccardo Proietti; Vidal Essebag
Journal:  Europace       Date:  2017-09-01       Impact factor: 5.214

2.  Physicians' clinical experience and its association with healthcare quality: a systematised review.

Authors:  Soffien Chadli Ajmi; Karina Aase
Journal:  BMJ Open Qual       Date:  2021-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.